| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $624.8M | +53.2% |
| Cost of Revenue | $96.6M | +46.1% |
| Gross Profit | $528.2M | +54.6% |
| R&D Expense | $116.5M | +69.8% |
| SG&A Expense | $452.0M | +40.9% |
| Operating Income | -$40.3M | +15.4% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$19.9M | +55.0% |
| Income Tax | $1.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $185.5M | -58.0% |
| Short-term Investments | $274.8M | +2698.5% |
| Accounts Receivable | $89.9M | +46.8% |
| Inventory | $33.9M | +185.1% |
| Current Assets | $593.7M | +12.0% |
| Total Assets | $676.8M | +19.8% |
| Current Liabilities | $78.1M | +27.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.7M | +113.1% |
| Capital Expenditures | $23.6M | +159.8% |
| Investing Cash Flow | -$294.8M | -1404.5% |
| Financing Cash Flow | $13.9M | -94.1% |
| Free Cash Flow | $1.0M | -58.6% |
| +103.4% |
| Net Income | -$21.2M | +52.9% |
| EPS (Basic) | -$0.72 | +55.0% |
| EPS (Diluted) | -$0.72 | +55.0% |
| Total Liabilities |
| $104.3M |
| +51.4% |
| Stockholders' Equity | $572.5M | +15.4% |